In addition, GCNT2/I-branched glycan expressing melanoma cells displayed higher levels of proapoptotic genes, BID and BAX, and had lower expression of prosurvival genes, BCL-2 and BCL-XL (Fig. 4i, j). This evidence concerns the gene BCL2 and melanoma.